Sennosides, Docusate Sodium is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Docusate Sodium; Sennosides.
Product ID | 70518-2288_912963c9-1cf0-176b-e053-2995a90af68e |
NDC | 70518-2288 |
Product Type | Human Otc Drug |
Proprietary Name | Sennosides, Docusate Sodium |
Generic Name | Sennosides, Docusate Sodium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-08-27 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Active Ingredient Strength | 50 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-08-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-08-27 |
Ingredient | Strength |
---|---|
DOCUSATE SODIUM | 50 mg/1 |
SPL SET ID: | 6973d747-0d8d-4f34-96af-d6f5e5a387ce |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0536-1167 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
0904-6723 | Sennosides, Docusate sodium | Sennosides, Docusate sodium |
55154-8076 | Sennosides, Docusate sodium | Sennosides, Docusate sodium |
69842-409 | SENNOSIDES, DOCUSATE SODIUM | SENNOSIDES, DOCUSATE SODIUM |
70000-0403 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
70000-0405 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
70518-2288 | Sennosides, Docusate Sodium | Sennosides, Docusate Sodium |
69618-049 | Sennosides and Docusate Sodium | Sennosides, Docusate Sodium |
69618-065 | Sennosides and Docusate Sodium | Sennosides, Docusate Sodium |